Inventor · disambiguated record
Werner Seeger
Also filed as: SEEGER WERNER
11 granted patents·12 pending applications·324 citations·filing 1992–2022
91Inventor score
Files withUNITED THERAPEUTICS CORP8MAX PLANCK GESELLSCHAFT4OLSCHEWSKI HORST2SEEGER WERNER2UNIV JUSTUS LIEBIG GIESSEN2
Top patents by PatentIndex Score
23 records- 0196US10716793B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2020·Granted Jul 21, 2020·11 cites·8 claims
- 0294US9358240B2Treprostinil administration by inhalationOLSCHEWSKI HORST·Filed 2009·Granted Jun 7, 2016·33 cites·9 claims
- 0394US9339507B2Treprostinil administration by inhalationOLSCHEWSKI HORST·Filed 2012·Granted May 17, 2016·38 cites·9 claims
- 0493US10376525B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2016·Granted Aug 13, 2019·13 cites·4 claims
- 0593US5589508AUse of an emulsion to prepare an intravensously administered medicament for treating skin diseasesFRESENIUS AG·Filed 1992·Granted Dec 31, 1996·210 cites·13 claims
- 0683US2023062605A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 0781US2022323459A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 0881US2022218720A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2022·Application pending·0 cites
- 0980US9486427B2Administration of aerosolised iloprostVECTURA GMBH·Filed 2013·Granted Nov 8, 2016·2 cites·13 claims
- 1079US11357782B2Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2021·Granted Jun 14, 2022·0 cites·11 claims
- 1170US2019365778A1Treprostinil administration by inhalationUNITED THERAPEUTICS CORP·Filed 2019·Application pending·0 cites
- 1263US2008200449A1Treprostinil administration using a metered dose inhalerUNITED THERAPEUTICS CORP·Filed 2007·Application pending·0 cites
- 1358US2022195529A1Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapyMAX PLANCK GESELLSCHAFT·Filed 2021·Application pending·0 cites
- 1457US2020181717A1Isoforms of gata6 and nkx2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapyMAX PLANCK GESELLSCHAFT·Filed 2019·Application pending·0 cites
- 1556US10501803B2Isoforms of GATA6 and NKX2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapyMAX PLANCK GESELLSCHAFT·Filed 2014·Granted Dec 10, 2019·0 cites·22 claims
- 1652US10821116B2Administration of iloprost as aerosol bolusVECTURA GMBH·Filed 2016·Granted Nov 3, 2020·0 cites·10 claims
- 1752US8124588B2Chimeric plasminogen activators and their pharmaceutical useSEEGER WERNER·Filed 2003·Granted Feb 28, 2012·2 cites·28 claims
- 1852US2025127716A1Inhaled imatinib for treatment of pulmonary hypertensionUNIV JUSTUS LIEBIG GIESSEN·Filed 2022·Application pending·0 cites
- 1951US6779521B1Combination mouthpiece for inhalation therapy devices used by oxygen dependent patientsPROFILE DRUG DELIVERY LTD·Filed 2000·Granted Aug 24, 2004·15 cites·17 claims
- 2050US2025000873A1Inhaled iloprost for rescue treatment and treatment as needed in pulmonary hypertensionUNIV JUSTUS LIEBIG GIESSEN·Filed 2021·Application pending·0 cites
- 2146US2006127485A1Bio-degradable colloid particles, in particular for pulmonary applicationsSEEGER WERNER·Filed 2003·Application pending·0 cites
- 2239US2014155486A1Administration of Iloprost as Aerosol BolusGESSLER TOBIAS·Filed 2012·Application pending·0 cites
- 2330US2018051344A1Embryonic isoforms of gata6 and nkx2-1 for use in lung cancer diagnosisMAX PLANCK GESELLSCHAFT·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Werner Seeger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →